On a day when the carnage was broad based, it was easy to find the stocks that were not getting killed. The trouble was, most of the early winners had reversals during the day and gave everything back. One of the few...(
read more)
• Monsanto Co. (NYSE:MON) reported its fiscal fourth-quarter loss of $0.22 cents a share, better than the Zacks Consensus Estimate of a loss of $0.27. Revenues rose...(
read more)
Acorda Therapeutics Inc. (ACOR) recorded adjusted earnings of 7 cents per share for the second quarter of fiscal 2011, compared with a loss of 18 cents in the year-ago...(
read more)